Cannabinoid R1/CB1/CNR1 Antibody (368302) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3834B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Biotin
Antibody Source
Recombinant Monoclonal Mouse IgG2A Clone # 368302
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
HEK293 human embryonic kidney cell line transfected with human Cannabinoid R1/CB1/CNR1
Met1-Leu472
Accession # NP_057167
Met1-Leu472
Accession # NP_057167
Specificity
Stains Cannabinoid R1/CB1/CNR1-transfected cells but not irrelevant transfectants.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for Cannabinoid R1/CB1/CNR1 Antibody (368302) [Biotin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cannabinoid R1/CB1/CNR1
Long Name
Cannabinoid Receptor 1
Alternate Names
CANN6, CannabinoidR1, CB-R, CB1, CB1A, CB1K5, CB1R, CNR1, SKR6R
Gene Symbol
CNR1
Additional Cannabinoid R1/CB1/CNR1 Products
Product Documents for Cannabinoid R1/CB1/CNR1 Antibody (368302) [Biotin]
Product Specific Notices for Cannabinoid R1/CB1/CNR1 Antibody (368302) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...